XWELL, Inc. (NASDAQ:XWEL ) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Company Participants Suzanne Scrabis – Chief Financial Officer Ezra Ernst – Chief Executive Officer Conference Call Participants Operator Good day, and welcome to the XWELL, Inc. Third Quarter 2024 Results Conference Call. All participants will be in a listen-only mode.
| Personal Care Products Industry | Consumer Staples Sector | Ezra T. Ernst CEO | XMUN Exchange | US98420U8027 ISIN |
| US Country | 246 Employees | - Last Dividend | 28 Sep 2023 Last Split | 5 Jan 2018 IPO Date |
XWELL Inc., previously known as XpresSpa Group, Inc., rebranded itself in October 2022 to better reflect its expanded focus on health and wellness services. Based in New York, New York, the company is engaged in providing spa and wellness services across various airports. It has established its presence through multiple brands, including XpresSpa, XpresTest, Treat, and HyperPointe, catering to the diverse needs of travelers. As of December 31, 2021, XWELL Inc. operates 52 locations across 24 airports in the United States, the Netherlands, and the United Arab Emirates, demonstrating its commitment to delivering accessible wellness solutions to the traveling public.
Under the XpresSpa brand, XWELL Inc. offers a variety of spa services tailored to the needs of travelers. These services include massages, along with nail and skin care treatments designed to provide relaxation and rejuvenation to individuals on-the-go. Additionally, the company markets spa and travel products, enhancing the travel experience with comfort and convenience.
XWELL Inc. extends its offerings to include retail products that cater to the wellness and travel needs of its customers. This range includes items that complement their spa services, embodying the company's holistic approach to health and wellness even outside its spa locations.
Recognizing the essential need for health services amidst a global pandemic, XWELL Inc., through its XpresTest and Treat brands, provides vital COVID-19 screening and testing services. This includes rapid testing not only for COVID-19 but also for other communicable diseases, such as influenza, RSV, and Flu A&B. Moreover, the company offers seasonal flu vaccination services, showcasing its commitment to public health and safety.
Beyond the confines of infectious disease testing, XWELL Inc. provides a broader spectrum of medical diagnostic testing services. This initiative ensures that travelers have access to essential health diagnostics, facilitating early detection and management of various health conditions.
To enhance accessibility and convenience for its customers, XWELL Inc. delivers its services through an integrated digital platform. This initiative is complemented by a relevant retail offering, furthering the company’s mission to provide comprehensive wellness and health solutions to the traveling public. This approach enables seamless access to XWELL’s array of services, ensuring travelers can easily avail themselves of health and wellness options regardless of their location.